Bill > SB191

This bill requires the Alabama Medicaid Agency to provide comprehensive coverage for postpartum depression (PPD) screening, ensuring that screenings follow evidence-based guidelines, are widely accessible to eligible women, and adequately reimburse healthcare professionals. The bill prohibits Medicaid from imposing step therapy protocols (a sequential drug approval process) for FDA-approved PPD treatment medications. Additionally, the Alabama Department of Public Health must develop and distribute educational materials about maternal mental health conditions, specifically PPD, including symptoms, coping methods, treatment options, and resources. These materials must be periodically reviewed and updated using current clinical guidelines and expert recommendations, and must be posted online and distributed in print form, with hospitals required to provide them to parents upon discharge. The bill also mandates that physicians and healthcare professionals assess birth mothers for PPD during postnatal or pediatric care, while allowing healthcare providers professional discretion in recommending treatment. Importantly, the bill includes a liability protection clause for healthcare professionals providing or not providing PPD-related information. The provisions of this bill will take effect on October 1, 2025, marking a significant step in addressing maternal mental health in Alabama.

Health and Social Services

https://alison.legislature.state.al.us/bill-search